Peel Hunt reissued their hold rating on shares of Assura PLC (LON:AGR) in a research note published on Monday.
Separately, Liberum Capital restated a buy rating and issued a GBX 68 ($0.90) target price on shares of Assura PLC in a report on Monday, August 7th.
Assura PLC (AGR) opened at 62.85 on Monday. The stock has a 50 day moving average price of GBX 64.05 and a 200 day moving average price of GBX 62.25. Assura PLC has a one year low of GBX 51.35 and a one year high of GBX 67.30. The company’s market cap is GBX 1.04 billion.
TRADEMARK VIOLATION WARNING: “Peel Hunt Reaffirms Hold Rating for Assura PLC (AGR)” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/05/peel-hunt-reaffirms-hold-rating-for-assura-plc-agr.html.
The company also recently disclosed a dividend, which will be paid on Wednesday, October 18th. Shareholders of record on Thursday, September 14th will be given a GBX 0.60 ($0.01) dividend. This represents a yield of 0.91%. The ex-dividend date of this dividend is Thursday, September 14th.
Assura PLC Company Profile
Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company’s property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston.
Receive News & Ratings for Assura PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura PLC and related companies with MarketBeat.com's FREE daily email newsletter.